Case Report : Cervical Cellular Angiofibroma

Article History

Submited : February 4, 2022
Published : October 21, 2022

Background: Cellular angiofibroma is a rare benign tumor in the distal genitalia introduced by Nucci et al in 1997 that can occur in both women and men with an age range of 46 – 54 years. In women it usually occurs in the vulva and vagina. These tumors are often diagnosed as Bartholin cysts, vulvar cysts, myomas, and unspecified complex tumors. Objective: Report a case of cellular angiofibroma previously diagnosed with cervical myoma Case: A 51-year-old female patient para 5 abortion 0 with complaints of lumps that have been felt to come in and out since 4 months but since 1 week it feels enlarged and cannot be inserted again, and diagnosed as cervical tumor. History of menopause since 1 year ago. The general condition of the patient is good with vital signs within normal limits. On physical examination of the abdomen, there was no tumor mass, tenderness or flux. On inspection, there was a reddish mass coming out of the vaginal introitus with some blackish necrotic appearance. On vaginal examination, a mass with a solid consistency was found with the impression of the cervix with a border of the tumor stalk that was not palpable. In this patient, Total Abdominal Hysterectomy and Bilateral Salpingoophorectomy were performed and the tissue was examined for anatomical pathology with cervical angiofibroma results with non-specific chronic inflammation and atypical complex endometrial gland hyperplasia.  Conclusion : Cellular angiofibroma is a rare tumor that usually occur in the vulva and vagina, which is often diagnosed as Bartholin's cyst, vulvar cyst, myoma and unspecified complex tumor. Action in the form of total excision of tumor tissue gives a low recurrence. Keywords : Cervical angiofibroma, cervical tumor


  1. Afandi, D. (2017) 'Basic principles of bioethics in ethical clinical decision making', Andalas Medical Magazine, 40(2), p. 111. doi: 10.22338/mka.v40.i2.p111-121.2017.
  2. Afiyah, RK et al. (2020) 'Recovery time period and quality of life after hysterectomy', Journal of Public Health Research, 9(2), pp. 176–178. doi: 10.4081/jphr.2020.1837.
  3. Ahmeti, F. (2016) 'Hysterectomy for Benign Conditions: Prophylactic Oophorectomy or Ovary Conservation', Obstetrics & Gynecology International Journal, 5(1), pp. 254–256. doi: 10.15406/ogij.2016.05.00142.
  4. Arega, C., Girma, W. and Sanchez Diaz, JM (2019) 'Angiofibroma of the Vagina Presenting with Abnormal Vaginal Bleeding: A Case Report from Ethiopia and Review of the Literature', Case Reports in Obstetrics and Gynecology, 2019 (July 2018), pp. 1–4. doi: 10.1155/2019/1486387.
  5. Butts, SF (2009) 'Choosing the route of hysterectomy for benign disease', Obstetrics and Gynecology, 114(5), pp. 1156–1158. doi: 10.1097/AOG.0b013e3181c33c72.
  6. Falcone, T. and Walters, MD (2008) 'Hysterectomy for benign disease', Obstetrics and Gynecology, 112(2), pp. 377–378. doi: 10.1097/AOG.0b013e318182ab79.
  7. John, Howard W; Rock, JA (2014) Te Linde's Operative Gynecology. Eleventh. Edited by JA John, Howard W; Rock. Norfolk, Virginia: Wolters Kluwer.
  8. Mandato, VD et al. (2015) 'Cellular angiofibroma in women: A review of the literature', Diagnostic Pathology, 10(1), pp. 1–10. doi:10.1186/s13000-015-0361-6.
  9. McCluggage, WG et al. (2004) 'Cellular angiofibroma and related fibromatous lesions of the vulva: Report of a series of cases with a morphological spectrum wider than previously described', Histopathology, 45(4), pp. 360–368. doi:10.1111/j.1365-2559.2004.01923.x.
  10. Van Mulders, S. et al. (2020) 'Cervicovaginal cellular angiofibroma', BMJ Case Reports, 13(7), pp. 1–4. doi: 10.1136/bcr-2020-235241.
  11. Nucci, Marisa; Parra-Herran, C. (2021) Gynecologic Pathology. Second. Edited by TR Harmon, Maureen ; Logani, Sanjay; Quinn. Philadelphia: Elseiver.
  12. Roberts, LW et al. (2005) 'Bioethics principles, informed consent, and ethical care for special populations: Curricular needs expressed by men and women physicians-in-training', Psychosomatics, 46(5), pp. 440–450. doi:10.1176/appi.psy.46.5.440.
  13. Shen, F. et al. (2017) 'The prevalence of malignant and borderline ovarian cancer in pre- and post-menopausal Chinese women', Oncotarget, 8(46), pp. 80589–80594. doi:10.18632/oncotarget.20384.
Hidayatullah, M. S., Arifuddin, S. ., & Rakhmah, N. . (2022). Case Report : Cervical Cellular Angiofibroma. Nusantara Medical Science Journal, 7(2), 114-118.


Download data is not yet available.